{"id":"W4386881349","doi":"10.1056/nejmoa2303815","title":"Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations","year":2023,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Brain Tumour Charity; Novartis Pharmaceuticals Corporation","keywords":"Dabrafenib; Trametinib; Glioma; Medicine; Oncology; Internal medicine; Cancer research; Biology; Melanoma; Genetics; MAPK/ERK pathway; Vemurafenib; Kinase; Metastatic melanoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009994084,0.0003640056,0.001078795,0.0002696416,0.0001221892,0.0002809362,0.0002229387,0.0003109966,0.001660071],"category_scores_gemma":[0.0009122264,0.0002220288,0.0008143434,0.0002847551,0.000217264,0.0002406147,0.0001682571,0.0007862726,0.0002310918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006543651,"about_ca_system_score_gemma":0.0007586205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001283483,"about_ca_topic_score_gemma":0.003221126,"domain_scores_codex":[0.9995736,0.0002782645,0.00002469455,0.00003999833,0.00003639052,0.00004709841],"domain_scores_gemma":[0.9995012,0.0001594641,0.0001524095,0.00002109489,0.00001791723,0.0001478924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6714734,0.005546072,0.04099992,0.001322776,0.002321504,0.0005542688,0.0001441337,0.003122433,0.01401012,0.0003426522,0.004070284,0.2560925],"study_design_scores_gemma":[0.2764456,0.5160359,0.1739449,0.0002873469,0.003609833,0.002803238,0.0002104455,0.006446927,0.01136007,0.0005544211,0.008242247,0.0000590403],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944806,0.00405666,0.000218466,0.0002317079,0.00005754853,0.0001815463,0.0001811003,0.00002445582,0.0005679916],"genre_scores_gemma":[0.996381,0.002359926,0.0004221719,0.0001115969,0.0000430804,0.0001423662,0.0001965894,0.000004332421,0.0003389462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001660071,"threshold_uncertainty_score":0.005553544,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02210377450626567,"score_gpt":0.2872056935525979,"score_spread":0.2651019190463322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}